QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

22,158 signal articles · 469 in last 24h · 106,818 total before filter · latest 17m ago
469last 24h
2496last 7d
492● bullish (7d)
246● bearish (7d)
200publishers
AllMacro200Earnings1542M&A125Regulatory15Product8Analyst24
✕ clear all filterssentiment: neutralSentiment:bullishneutralbearishshow all (incl. clickbait)
Treasury Yields, Dollar Decline as U.S.-Iran Deal Materializes
Barrons.com53d agoneutral
Treasury Yields, Dollar Decline as U.S.-Iran Deal Materializes

Treasury yields and the dollar slip as President Trump and Iran agree to sign a peace deal later this week while markets brace for the first Fed meeting under Chairman Warsh. The U.S.-Iran pact is expected to restore normal oil trade through the Strait of Hormuz.

Buy, Hold, or Sell: Dropping 39% From Its All-Time High Under a Hawkish New Fed, Is Netflix an Absolute Buy at $81?
24/7 Wall St.53d agoneutral
Buy, Hold, or Sell: Dropping 39% From Its All-Time High Under a Hawkish New Fed, Is Netflix an Absolute Buy at $81?

At $81.27, Netflix (NASDAQ:NFLX) screens as compelling for investors researching quality growth at compressed multiples. A 39% drawdown from the all-time high has compressed one of the highest-quality compounders in media to a forward multiple that finally looks reasonable, just as the advertising business approaches scale. Netflix runs the world’s largest paid streaming service with ... Buy, Hold, or Sell: Dropping 39% From Its All-Time High Under a Hawkish New Fed, Is Netflix an Absolute Buy a

A Dramatic Shift in Fed Policy Just Unlocked a New Era for Bristol Myers Squibb
24/7 Wall St.53d agoneutral
A Dramatic Shift in Fed Policy Just Unlocked a New Era for Bristol Myers Squibb

With the 10-Year Treasury yielding 4.48% and the Fed signaling more cuts ahead, income investors are hunting for yield that compounds. Bristol Myers Squibb (NYSE:BMY) offers a 4.39% yield backed by 94 consecutive years of dividend payments. The pharma giant is rebuilding around a Growth Portfolio (Eliquis, Camzyos, Breyanzi) while legacy drugs face generic erosion. ... A Dramatic Shift in Fed Policy Just Unlocked a New Era for Bristol Myers Squibb

Buy, Hold, or Sell: Lam Research Rocketed 21% Off Its June Lows as a New Fed Begins. Is LRCX Worthwhile at $366?
24/7 Wall St.53d agoneutral
Buy, Hold, or Sell: Lam Research Rocketed 21% Off Its June Lows as a New Fed Begins. Is LRCX Worthwhile at $366?

At $366.81, Lam Research (NASDAQ:LRCX) trades in a zone where valuation and momentum are in tension. The stock has rocketed 20.95% in the past week as softer rates and a fresh Fed posture reset risk appetite across semicap. Lam designs deposition and etch tools for leading-edge logic, high-bandwidth memory, and 3D NAND. Q3 FY26 revenue ... Buy, Hold, or Sell: Lam Research Rocketed 21% Off Its June Lows as a New Fed Begins. Is LRCX Worthwhile at $366?

Traders Reduce Bets on a Fed Rate Rise This Year
The Wall Street Journal53d agoneutral
Traders Reduce Bets on a Fed Rate Rise This Year

News of a deal between Washington and Tehran that could reopen the Strait of Hormuz has prompted investors to pare back bets on higher rates this morning. The thinking: If oil starts flowing more freely, energy prices would likely fall, reducing inflationary pressure and giving the Fed less reason to increase rates. It's a reversal from just a week ago, when investors were still digesting news of a stronger-than-expected May jobs report.

Five Key Market Themes Investors Will Be Watching This Week
InvestorsHub53d agoneutral
Five Key Market Themes Investors Will Be Watching This Week

A preliminary peace agreement between the United States and Iran has emerged as the dominant market story at the start of the week, with investors assessing the implications for energy markets, inflation and central bank policy. Attention is also focused on a series of interest-rate decisions from major central banks, the post-IPO performance of SpaceX (NASDAQ:SPCX), and developments surrounding AI company Anthropic (NASDAQ:ANTP).

Xbox fans waiting on Project Helix get unexpected news from Wedbush
TheStreet54d agoneutral
Xbox fans waiting on Project Helix get unexpected news from Wedbush

The explosion in AI spending is having a ripple effect throughout the tech industry, and now gamers are going to pay the price. To find out just how much weight AI holds in the U.S. economy, the Federal Reserve Bank of St. Louis looked at how much money is being spent on software, R&D and ...

Stock Market Week Ahead: Keep An Eye On The Little Things
Investor's Business Daily55d agoneutral
Stock Market Week Ahead: Keep An Eye On The Little Things

The past week's stock market saw the S&P 500 and the Nasdaq composite test, then bounce off support at their 50-day moving averages. The S&P 500 then rose, on Friday, to briefly test resistance at its 21-day exponential moving average. The Nasdaq did not rise to this level. The Nasdaq 100, however, as tracked by the Invesco QQQ Trust Series...